AnaptysBio Q4 EPS $1.79 Beats $0.80 Estimate, Sales $108.240M Beat $92.051M Estimate

AnaptysBio (NASDAQ:ANAB) reported quarterly earnings of $1.79 per share which beat the analyst consensus estimate of $0.80 by 124.87 percent. This is a 348.61 percent increase over losses of $(0.72) per share from the same period last year. The company reported quarterly sales of $108.240 million which beat the analyst consensus estimate of $92.051 million by 17.59 percent. This is a 151.06 percent increase over sales of $43.113 million the same period last year.